Psoriasis Pipeline Update: JNJ-2113, A Novel Oral IL-23 Receptor Antagonist Peptide, Shows Promise in a Phase 2b Study

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

PsO, PsA, and HS: Dr. Gottlieb
PsO, PsA, and HS: Dr. Gottlieb
Psoriasis
PsO, PsA, and HS: Dr. Gottlieb
- Alice Gottlieb, MD, PhD
Verrucous Psoriasis: A Rare Variant Refractory to Topical Steroids
Verrucous Psoriasis: A Rare Variant Refractory to Topical Steroids
Psoriasis
Verrucous Psoriasis: A Rare Variant Refractory to Topical Steroids
- George Jeha, MD
- Deborah Hilton, MD
- Maria Bao-Loc-Trung, BS
IFPA World PsO and PsA Conference
IFPA World PsO and PsA Conference
Psoriasis
IFPA World PsO and PsA Conference
- Wilson Liao, MD
"Psleep": Psoriasis and Sleep
"Psleep": Psoriasis and Sleep
Psoriasis
"Psleep": Psoriasis and Sleep
- Annelies Isabelle Johanna Groen
- Jennifer Cather, MD